Ignite Creation Date:
2025-12-24 @ 2:48 PM
Ignite Modification Date:
2026-02-02 @ 5:46 AM
Study NCT ID:
NCT00619359
Status:
COMPLETED
Last Update Posted:
2017-03-21
First Post:
2008-01-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02
Start Date Type:
None
Primary Completion Date:
2009-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-06
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-28
First Submit QC Date:
None
Study First Post Date:
2008-02-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-01-19
Results First Submit QC Date:
None
Results First Post Date:
2010-02-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-14
Last Update Post Date:
2017-03-21
Last Update Post Date Type:
ACTUAL